Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Clinical Lung Cancer|March 25, 2022
Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung CancerRamaswamy Govindan, Mike Lind, Amelia Insa, et al.
Cancer Cell|January 5, 2024
Interferon-stimulated neutrophils as a predictor of immunotherapy responseMadeleine Benguigui, Tim J Cooper, Prajakta Kalkar, et al.
Cancer Medicine|March 21, 2022
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancerBenjamin Solomon, Ana Callejo, Jair Bar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2021
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU StudyMelissa L Johnson, Zanete Zvirbule, Konstantin Laktionov, et al.
NPJ Precision Oncology|January 19, 2026
Validation of histopathology-based deep learning algorithms for detection of actionable non-small cell lung cancer biomarkersChristian Rolfo, Efrat Ofek, Yoash Barak, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2025
A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancerByoung Chul Cho, Melissa Johnson, Jair Bar, et al.
Clinical and Translational Radiation Oncology|March 11, 2026
Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapyAndrea R Filippi, Jair Bar, Daniel C Christoph, et al.
The British Journal of Radiology|March 14, 2019
Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomesSarit Appel, Jair Bar, Alon Ben-Nun, et al.
Lung Cancer (Amsterdam, Netherlands)|February 29, 2024
Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer: KEYNOTE-782Jair Bar, Emilio Esteban, Delvys Rodríguez-Abreu, et al.
Brain : a Journal of Neurology|October 25, 2024
CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasisSahar Israeli Dangoor, Rami Khoury, Koren Salomon, et al.
Pageof 12